Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Leukemia|April 2, 2004
Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemiaL J Hak, M V Relling, C Cheng, et al.
Pharmacotherapy|January 1, 1992
Variability in teniposide plasma protein binding is correlated with serum albumin concentrationsW P Petros, J H Rodman, M V Relling, et al.
The Journal of Pediatrics|April 1, 1989
Lorazepam pharmacodynamics and pharmacokinetics in childrenM V Relling, R K Mulhern, R K Dodge, et al.
Blood|July 15, 1994
Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemiaJ C Barredo, T W Synold, J Laver, et al.
Leukemia|January 1, 1996
Allopurinol inhibits de novo purine synthesis in lymphoblasts of children with acute lymphoblastic leukemiaE Masson, T W Synold, M V Relling, et al.
Seminars in Hematology|July 1, 1991
Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemiaW E Evans, J Rodman, M V Relling, et al.
Clinical Pharmacology and Therapeutics|September 11, 2009
Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemiaJ C Panetta, A Gajjar, N Hijiya, et al.
Pharmaceutical Research|September 16, 2000
Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoproteinC Brimer, J T Dalton, Z Zhu, et al.
Mutation Research|November 7, 1998
The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapyJ C Fuscoe, G W Knapp, N M Hanley, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemiaW E Evans, M Abromowitch, W R Crom, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Leukemia|April 2, 2004
Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemiaL J Hak, M V Relling, C Cheng, et al.
Pharmacotherapy|January 1, 1992
Variability in teniposide plasma protein binding is correlated with serum albumin concentrationsW P Petros, J H Rodman, M V Relling, et al.
The Journal of Pediatrics|April 1, 1989
Lorazepam pharmacodynamics and pharmacokinetics in childrenM V Relling, R K Mulhern, R K Dodge, et al.
Blood|July 15, 1994
Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemiaJ C Barredo, T W Synold, J Laver, et al.
Leukemia|January 1, 1996
Allopurinol inhibits de novo purine synthesis in lymphoblasts of children with acute lymphoblastic leukemiaE Masson, T W Synold, M V Relling, et al.
Seminars in Hematology|July 1, 1991
Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemiaW E Evans, J Rodman, M V Relling, et al.
Clinical Pharmacology and Therapeutics|September 11, 2009
Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemiaJ C Panetta, A Gajjar, N Hijiya, et al.
Pharmaceutical Research|September 16, 2000
Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoproteinC Brimer, J T Dalton, Z Zhu, et al.
Mutation Research|November 7, 1998
The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapyJ C Fuscoe, G W Knapp, N M Hanley, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemiaW E Evans, M Abromowitch, W R Crom, et al.
Pageof 18